Freelance science journalist, covering drugs, clinical trials, biotech, pharma and more. Writes for Nature, The Lancet, The New Scientist, and others.

Search Tweets

Twitter Feed

@AsherMullard — 665 followers, 244 tweets

Can innate immune system targets heat up 'cold' tumours, making them responsive to immunotherapy? Novartis, BMS, Merck, and others hope so, via @NatRevDrugDisc https://t.co/ZakuNuu6je. https://t.co/dNfUN8U52D
Amgen CSO Sean Harper discusses the many uses of genetic data in drug discovery, 5 years on from their deCODE acquisition https://t.co/EuK5Ez6wm7. Lessons from LCAT, CETP, PCSK9, ASGR1, sclerostin and so much more. via @NatRevDrugDisc https://t.co/9cfAEJoBxT
@CT_Morrison @NatRevDrugDisc I should have taken the Dec 15 double or nothing...
Show More